NTLA

NTLA Net Income Growth

16.71%TTM

Period ending:

NTLA TTM Net Income YoY %%
NTLA TTM Net Income YoY %46.59%-176.79%
2016-06-302026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

NTLA net income growth history

Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 41 observations from Jun 30, 2016 to Jun 30, 2026.

Intellia Therapeutics Inc Net Income Growth — Trailing twelve months (TTM)
Period endingNet Income Growth
16.7055%
24.9695%
20.4861%
14.643%
5.6215%
-8.3238%
-7.8615%
-12.9414%
-12.2073%
-12.792%
-1.4775%
-4.6202%
-13.2387%
-16.79%
-77.0064%
-93.1491%
-116.3989%
-147.9708%
-99.5754%
-90.2065%
-59.3701%
-35.8605%
-34.8608%
-33.2053%
-29.8889%
-27.3162%
-16.627%
-0.092%
-7.8377%
-12.6646%
-26.3536%
-66.6697%
-79.1567%
-102.97%
-113.5139%
-105.7418%
-111.7284%
-108.8368%
-155.1746%
-83.1506%
-89.5728%

Compare net income growth

Other companies in Health Care. Each page shows its own reporting periods and currency.

Compare all covered stocks by net income growth →

All NTLA financial metrics · NTLA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.